Involvement of Prolonged Ras Activation in Thrombopoietin-Induced Megakaryocytic Differentiation of a Human Factor-Dependent Hematopoietic Cell Line

ABSTRACT Thrombopoietin (TPO) is a hematopoietic growth factor that plays fundamental roles is both megakaryopoiesis and thrombopoiesis through binding to its receptor, c-mpl. Although TPO has been shown to activate various types of intracellular signaling molecules, such as the Janus family of protein tyrosine kinases, signal transducers and activators of transcription (STATs), and ras, the precise mechanisms underlying TPO-induced proliferation and differentiation remain unknown. In an effort to clarify the mechanisms of TPO-induced proliferation and differentiation, c-mpl was introduced into F-36P, a human interleukin-3 (IL-3)-dependent erythroleukemia cell line, and the effects of TPO on the c-mpl-transfected F-36P (F-36P-mpl) cells were investigated. F-36P-mpl cells were found to proliferate and differentiate at a high rate into mature megakaryocytes in response to TPO. Dominant-negative (dn) forms of STAT1, STAT3, STAT5, and ras were inducibly expressed in F-36P-mpl cells, and their effects on TPO-induced proliferation and megakaryocytic differentiation were analyzed. Among these dn molecules, both dn ras and dn STAT5 reduced TPO- or IL-3-induced proliferation of F-36P-mpl cells by ∼30%, and only dn ras could inhibit TPO-induced megakaryocytic differentiation. In accord with this result, overexpression of activated ras (H-rasG12V) for 5 days led to megakaryocytic differentiation of F-36P-mpl cells. In a time course analysis on H-rasG12V-induced differentiation, activation of the ras pathway for 24 to 28 h was required and sufficient to induce megakaryocytic differentiation. Consistent with this result, the treatment of F-36P-mpl cells with TPO was able to induce prolonged activation of ras for more than 24 h, whereas IL-3 had only a transient effect. These results suggest that prolonged ras activation may be involved in TPO-induced megakaryocytic differentiation.

[1]  I. Dusanter-Fourt,et al.  Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway , 1997, Molecular and cellular biology.

[2]  G. Feldman,et al.  STAT5A-deficient mice demonstrate a defect in granulocyte-macrophage colony-stimulating factor-induced proliferation and gene expression. , 1997, Blood.

[3]  A. Miyajima,et al.  A possible involvement of Stat5 in erythropoietin-induced hemoglobin synthesis. , 1997, Biochemical and biophysical research communications.

[4]  Y. Matsuzawa,et al.  Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21(WAF1/Cip1) by STAT5 , 1997, Molecular and cellular biology.

[5]  N. Ahn,et al.  Megakaryocytic differentiation induced by constitutive activation of mitogen-activated protein kinase kinase , 1997, Molecular and cellular biology.

[6]  A. Yoshimura,et al.  STAT5 Activation Correlates with Erythropoietin Receptor-mediated Erythroid Differentiation of an Erythroleukemia Cell Line* , 1997, The Journal of Biological Chemistry.

[7]  K. Kaushansky,et al.  Dissecting the thrombopoietin receptor: functional elements of the Mpl cytoplasmic domain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Bos,et al.  Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras , 1997, Oncogene.

[9]  L. Hennighausen,et al.  Stat5a is mandatory for adult mammary gland development and lactogenesis. , 1997, Genes & development.

[10]  M. Grossi,et al.  Transcriptional down-regulation of myogenin expression is associated with v-ras-induced block of differentiation in unestablished quail muscle cells , 1997, Oncogene.

[11]  W. Alexander,et al.  Tyrosine‐599 of the c‐Mpl receptor is required for Shc phosphorylation and the induction of cellular differentiation. , 1996, The EMBO journal.

[12]  T. Hirano,et al.  Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. , 1996, Immunity.

[13]  H. Miyazaki,et al.  Functional analysis of the cytoplastic domain of the human Mpl receptor for tyrosine‐phosphorylation of the signaling molecules, proliferation and differentiation , 1996 .

[14]  Y. Matsuzawa,et al.  The biologic properties of recombinant human thrombopoietin in the proliferation and megakaryocytic differentiation of acute myeloblastic leukemia cells. , 1996, Blood.

[15]  F. Verdier,et al.  Erythropoietin‐induced erythroid differentiation of the human erythroleukemia cell line TF‐1 correlates with impaired STAT5 activation. , 1996, The EMBO journal.

[16]  T. Hirano,et al.  A central role for Stat3 in IL‐6‐induced regulation of growth and differentiation in M1 leukemia cells. , 1996, The EMBO journal.

[17]  I. Dusanter-Fourt,et al.  Functional regions of the mouse thrombopoietin receptor cytoplasmic domain: evidence for a critical region which is involved in differentiation and can be complemented by erythropoietin , 1996, Molecular and cellular biology.

[18]  J. Ihle.  STATs: Signal Transducers and Activators of Transcription , 1996, Cell.

[19]  F. D. de Sauvage,et al.  Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin , 1996, The Journal of experimental medicine.

[20]  M. Xia,et al.  Megakaryocyte growth and development factor and interleukin-3 induce patterns of protein-tyrosine phosphorylation that correlate with dominant differentiation over proliferation of mpl-transfected 32D cells. , 1995, Blood.

[21]  Y. Kaziro,et al.  Ras Is Not Required for the Interleukin 3-induced Proliferation of a Mouse Pro-B Cell Line, BaF3 (*) , 1995, The Journal of Biological Chemistry.

[22]  J. Ihle.  Cytokine receptor signalling , 1995, Nature.

[23]  K. Kaushansky.  Thrombopoietin the primary regulator of platelet production. , 1995, Trends in endocrinology and metabolism: TEM.

[24]  R. Hoffman,et al.  Signal transduction by the receptors for thrombopoietin (c-mpL) and interleukin-3 in hematopoietic and nonhematopoietic cells. , 1995, Blood.

[25]  I. Matsumura,et al.  Growth response of acute myeloblastic leukemia cells to recombinant human thrombopoietin. , 1995, Blood.

[26]  S. Ng,et al.  Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells , 1995, Molecular and cellular biology.

[27]  T. Boone,et al.  Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nonhuman primates. , 1995, Blood.

[28]  A. Gurney,et al.  Distinct regions of c-Mpl cytoplasmic domain are coupled to the JAK-STAT signal transduction pathway and Shc phosphorylation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[29]  D. Levy,et al.  Thrombopoietin activates a STAT5‐like factor in hematopoietic cells. , 1995, The EMBO journal.

[30]  菅原 浩之.  Induction of programmed cell death in human hematopoietic cell lines by fibronectin via its interaction with very late antigen 5 , 1995 .

[31]  R. Schreiber,et al.  In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells. , 1994, Blood.

[32]  S. Yuspa,et al.  Alterations in murine keratinocyte differentiation induced by activated rasHa genes are mediated by protein kinase C-alpha. , 1994, Cancer research.

[33]  A. Gurney,et al.  Thrombocytopenia in c-mpl-deficient mice. , 1994, Science.

[34]  D. Stacey,et al.  Cellular ras activity is required for passage through multiple points of the G0/G1 phase in BALB/c 3T3 cells , 1994, Molecular and cellular biology.

[35]  H. Kitayama,et al.  Induction of programmed cell death in human hematopoietic cell lines by fibronectin via its interaction with very late antigen 5 , 1994, The Journal of experimental medicine.

[36]  F. McCormick,et al.  Activators and effectors of ras p21 proteins. , 1994, Current opinion in genetics & development.

[37]  T. Hirano,et al.  Identification of a novel interleukin-6 response element containing an Ets-binding site and a CRE-like site in the junB promoter , 1993, Molecular and cellular biology.

[38]  S. Green,et al.  PC12 cell neuronal differentiation is associated with prolonged p21ras activity and consequent prolonged ERK activity , 1992, Neuron.

[39]  Y. Yazaki,et al.  Establishment and erythroid differentiation of a cytokine-dependent human leukemic cell line F-36: a parental line requiring granulocyte-macrophage colony-stimulating factor or interleukin-3, and a subline requiring erythropoietin. , 1991, Blood.

[40]  S. Hirohashi,et al.  Monoclonal antibody highly sensitive for the detection of ras p21 in immunoblotting analysis. , 1987, Japanese journal of cancer research : Gann.

[41]  J. Bennett,et al.  Interaction of AP-2, a monoclonal antibody specific for the human platelet glycoprotein IIb-IIIa complex, with intact platelets. , 1983, The Journal of biological chemistry.

[42]  T. Vik,et al.  Activation of the mitogen-activated protein kinase pathway is involved in and sufficient for megakaryocytic differentiation of CMK cells. , 1997, Blood.

[43]  H. Miyazaki,et al.  Functional analysis of the cytoplasmic domain of the human Mpl receptor for tyrosine-phosphorylation of the signaling molecules, proliferation and differentiation. , 1996, FEBS letters.

[44]  A. Marchetti,et al.  Ras oncogene transformation of human B lymphoblasts is associated with lymphocyte activation and with a block of differentiation. , 1993, Oncogene.

[45]  G. Rovera,et al.  The immediate early gene response to a differentiative stimulus is disrupted by the v-abl and v-ras oncogenes. , 1992, Oncogene.